2022年 欧文
1) Kasahara H, Shimizu K, Makioka K, Sano T, Ohtaki Y, Ikeda Y. Multimodal
immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated
multiorgan autoimmunity. Immunol Res. 2022; 70: 414-418.
2) Furuta M, Sato M, Tsukagoshi S, Tsushima Y, Ikeda Y. Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles. J Neurol Sci. 2022; 438: 120281.
3) Furuta M, Sato M, Kasahara H, Tsukagoshi S, Hurayanagi K, Fujita Y, Takai
E, Aihara Y, Okamoto K, and Ikeda Y. Clinical, radiological, and molecular
analyses of neuronal intranuclear inclusion disease with polyglycine inclusions.
J Neurol Sci. 2023; 448: 120618.
4) Shibata M, Makioka K, Hamaguchi Y, Ikeda Y. Comment on:Favourable complete
remission of anti-OJ antibody-positive myosis after lung cancer resection:Reply.
Rheumatology(Oxgord). 2022; 61: e235.
5) Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hashino M, Itoh K, Ihara
K, Nakaji S, Takatama M, Ikeda Y, and Shoji M. (in pres) Plasma ApoE4 levels
are lower than ApoE2 and ApoE3 levels, and not associated with plasma Aβ40/42
ratio as a biomarker of Aβ amyloidosis in Alzheimer's disease. J Alzheimers
Dis.
6) Kawarabayashi T, Nakamura T, Sato K, Seino Y, Ichii S, Nakahata N, Takatama
M, Wastaway D, George-Hyslop PS, Shoji M. Lipid Rafts Act as a Common Platform
for Amyloyd-β Oligomer-Induced Alzheimer's Disease Pathology. J Alzheimers
Dis. 2022; 87(3): 1189-1203.
7) Maruyama K, Shibata M, Nagashima K, Abe T, Ikeda Y. A case of idiopathic
intracardiac and pulmonary arterial thrombosis successfuly treated with
surgical thrombectomy. Neurology and Clinical Neuroscience. 2022; 10(3):
167-169.
8) Takazawa T, Horiuchi T, Orihara M, Nagumo K, Tomioka A, Ideno Y, Hayashi
K, Yashima H, Araki T, Hatayama K, Terauchi M, Ikea Y, Saito S. Prevention
of Postoperative Cognitive Dysfunction by Minocycline in Elderly Patients
after Total Knee Arthroplasty:A Eandmizes, Double-blind, Placebo-controlled
Clinical Trial. Anesthesiology. 2023; 138: 172-183.
|
